Related Experiment Video
Updated: Apr 13, 2026

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
Published on: November 8, 2016
The issue of immunology in stem cell therapies: a pharmaceutical perspective
Richard Haworth1, Michaela Sharpe
1Safety Assessment, GlaxoSmithKline R&D, Park Road, Ware, Herts., SG12 0DP, UK.
Abstract:
Cautious approaches in the clinic are currently proposed, supported by relevant in vitro, in vivo and published data. Key to developing our understanding of the risks of immune rejection of stem cell based therapies will be the inclusion of immunological endpoints in clinical trials and the sharing of data. There is likely not a one-size-fits all strategy but one dependent on cell therapy, mode of action and disease indication.
Related Concept Videos
Regulation of Hematopoietic Stem Cells
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
iPS Cell Differentiation
Stem Cell Culture
Induced Pluripotent Stem Cells
Somatic...
Induced Pluripotent Stem Cells

